DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Amiot A, Serrero M, Peyrin-Biroulet L. et al.
One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.
Aliment Pharmacol Ther 2017;
46: 310-321
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.